Currently Viewing:
Supplements The Clinical, Social, and Economic Implications of Neurogenic Bladder in Managed Care: Optimizing Pa
The Epidemiology and Pathophysiology of Neurogenic Bladder
David Ginsberg, MD
Optimizing Therapy and Management of Neurogenic Bladder
David Ginsberg, MD
Managed Care Aspects of Managing Neurogenic Bladder/Neurogenic Detrusor Overactivity
William J. Cardarelli, PharmD
Currently Reading
Participating Faculty: The Clinical, Social, and Economic Implications of Neurogenic Bladder in Managed Care: Optimizing Patient Management and Outcomes

Participating Faculty: The Clinical, Social, and Economic Implications of Neurogenic Bladder in Managed Care: Optimizing Patient Management and Outcomes

This supplement to The American Journal of Managed Care is intended to provide an understanding of the pathophysiology of neurogenic bladder (NGB) and its impact on patient health and quality of life. The discussion will include an overview of appropriate diagnosis and assessment of patients with NGB/neurogenic detrusor overactivity and a review of roles, benefits, and risks of approved and emerging therapies. Also included is an analysis of economic and healthcare utilization impact associated with NGB and its consequences.
Faculty

David Ginsberg, MD
Associate Professor of Clinical Urology
Department of Urology
Keck School of Medicine
University of Southern California
Los Angeles, California

Chief, Department of Urology
Rancho Los Amigos National Rehabilitation Center
Downey, California

William J. Cardarelli, PharmD
Director of Pharmacy Revenue and Supply
Atrius Health
Harvard Vanguard Medical Associates
Watertown, Massachusetts

Contributing Editorial Support

Elizabeth Paczolt, MD, FACNM
Medical Consultant
Churchville, Pennsylvania


This activity is supported by an educational grant from Allergan, Inc.


Faculty Disclosures
These faculty have disclosed the following relevant commercial financial relationships or affiliations in the past 12 months.

David Ginsberg, MD
Consultant or paid advisory board/honoraria: Allergan, Inc, American Medical Systems, and Pfizer
Lecture fees for speaking at the invitation of a commercial sponsor: Allergan, Inc

William J. Cardarelli, PharmD, and Elizabeth Paczolt, MD, FACNM, have no relevant financial relationships with commercial interests to disclose.

The American Journal of Managed Care
Publishing Staff—Jeff D. Prescott, PharmD, RPh; Kara Guarini, MS; and Ida Delmendo have no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Office of Continuing Professional Education
Planning Staff—Judy V. Lum, MPA; David Heckard; Elena Beyzarov, PharmD; Donna W. Fausak; Ann C. Lichti, CCMEP; and Steve Lin, PharmD, RPh, have no relevant financial relationships with commercial interests to disclose.

University of Cincinnati
Planning Staff—Susan P. Tyler, MEd, CMP, CCMEP, has no relevant financial relationships with commercial interests to disclose.
Physician Reviewer—Rick Ricer, MD, has no relevant financial relationships with commercial interests to disclose.

Signed disclosures are on file at the office of The American Journal of Managed Care, Plainsboro, New Jersey.
PDF
 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up